Rose Research Center, LLC

Rose Research Center, LLC is dedicated to advancing clinical trials and medical research, focusing on tobacco dependence and addiction. The center provides innovative solutions for smoking cessation and tobacco harm reduction through comprehensive study protocols. Founded in 2014, Rose Research Center, LLC is headquartered in Raleigh, North Carolina, and specializes in clinical trials and medical research focused on tobacco dependence. The company was established to advance understanding of addiction and smoking cessation, led by CEO Jed Rose, who has a background in researching tobacco use and addiction.

Rose Research Center (RRC) conducts clinical trials and medical research studies with a specialized emphasis on tobacco dependence research. The center offers a broad spectrum of study protocols aimed at understanding addiction, smoking cessation, and tobacco harm reduction. Operating in Raleigh and Charlotte, North Carolina, RRC serves a diverse client base, including smokers seeking cessation, healthcare providers, and pharmaceutical companies interested in research collaborations. Participants can access investigational drugs, medical devices, and behavioral interventions that address significant health concerns related to tobacco use.

The revenue model of Rose Research Center is built upon partnerships and transactions with stakeholders, including pharmaceutical companies and healthcare organizations. Revenue is generated through participant compensation for contributions to studies and contracts with research sponsors. Funding sources include research grants and clinical trial agreements, with study participants receiving products and medications at no cost, further engaging them in the research process.